慢性肾病和肺动脉高压：诊断和治疗的进展。

IF 6.4 2区医学 Q1 MEDICAL LABORATORY TECHNOLOGY

Translational Research Pub Date : 2024-07-01 DOI:10.1016/j.trsl.2024.06.003

Shanshan Yuan , Shicheng Li , Jiangwen Ruan , Hui Liu , Tongmeng Jiang , Hongyan Dai

{"title":"慢性肾病和肺动脉高压：诊断和治疗的进展。","authors":"Shanshan Yuan , Shicheng Li , Jiangwen Ruan , Hui Liu , Tongmeng Jiang , Hongyan Dai","doi":"10.1016/j.trsl.2024.06.003","DOIUrl":null,"url":null,"abstract":"<div><p>Pulmonary hypertension (PH) is a medical condition characterized by elevated pulmonary vascular resistance and pressure, resulting from different diseases. Due to their high occurrence of PH, intricate hemodynamic classification, and frequently multifactorial cause and mechanism, individuals suffering from chronic kidney disease (CKD) are categorized as the fifth primary group of PH. Based on both domestic and international research, this article provides information on the epidemiology, risk factors, pathogenesis, and targeted drug treatment of PH associated with CKD.</p></div>","PeriodicalId":23226,"journal":{"name":"Translational Research","volume":"273 ","pages":"Pages 16-22"},"PeriodicalIF":6.4000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Chronic kidney disease and pulmonary hypertension: Progress in diagnosis and treatment\",\"authors\":\"Shanshan Yuan , Shicheng Li , Jiangwen Ruan , Hui Liu , Tongmeng Jiang , Hongyan Dai\",\"doi\":\"10.1016/j.trsl.2024.06.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Pulmonary hypertension (PH) is a medical condition characterized by elevated pulmonary vascular resistance and pressure, resulting from different diseases. Due to their high occurrence of PH, intricate hemodynamic classification, and frequently multifactorial cause and mechanism, individuals suffering from chronic kidney disease (CKD) are categorized as the fifth primary group of PH. Based on both domestic and international research, this article provides information on the epidemiology, risk factors, pathogenesis, and targeted drug treatment of PH associated with CKD.</p></div>\",\"PeriodicalId\":23226,\"journal\":{\"name\":\"Translational Research\",\"volume\":\"273 \",\"pages\":\"Pages 16-22\"},\"PeriodicalIF\":6.4000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1931524424001385\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICAL LABORATORY TECHNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Research","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1931524424001385","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

肺动脉高压（PH）是一种由不同疾病引起的以肺血管阻力和压力升高为特征的病症。由于肺动脉高压发生率高、血流动力学分类复杂、病因和机制往往是多因素的，慢性肾脏病（CKD）患者被列为肺动脉高压的第五个主要群体。本文在国内外研究的基础上，介绍了与 CKD 相关的 PH 的流行病学、危险因素、发病机制和靶向药物治疗。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Chronic kidney disease and pulmonary hypertension: Progress in diagnosis and treatment

Pulmonary hypertension (PH) is a medical condition characterized by elevated pulmonary vascular resistance and pressure, resulting from different diseases. Due to their high occurrence of PH, intricate hemodynamic classification, and frequently multifactorial cause and mechanism, individuals suffering from chronic kidney disease (CKD) are categorized as the fifth primary group of PH. Based on both domestic and international research, this article provides information on the epidemiology, risk factors, pathogenesis, and targeted drug treatment of PH associated with CKD.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Translational Research 医学-医学：内科

CiteScore

15.70

自引率

0.00%

发文量

195

审稿时长

14 days

期刊介绍： Translational Research (formerly The Journal of Laboratory and Clinical Medicine) delivers original investigations in the broad fields of laboratory, clinical, and public health research. Published monthly since 1915, it keeps readers up-to-date on significant biomedical research from all subspecialties of medicine.